Search research articles
Contact Us
Filters
Showing results (21-30 of 40) with videos related to
Page
of 4
Sort By:
Infection and Immunity
|
February 9, 2011
Preterm infants have deficient monocyte and lymphocyte cytokine responses to group B streptococcus
Andrew J Currie, Samantha Curtis, Tobias Strunk, et al.
The Journal of Pediatrics
|
April 8, 2004
Primary immunodeficiency to pneumococcal infection due to a defect in Toll-like receptor signaling
Andrew J Currie, Donald J Davidson, Gregor S D Reid, et al.
Immunity, Inflammation and Disease
|
November 11, 2017
T-cell responses against rhinovirus species A and C in asthmatic and healthy children
Cibele M Gaido, Caitlyn Granland, Ingrid A Laing, et al.
European Journal of Immunology
|
October 16, 2014
Tumor-infiltrating dendritic cells exhibit defective cross-presentation of tumor antigens, but is reversed by chemotherapy
Alison M McDonnell, Willem Joost Lesterhuis, Andrea Khong, et al.
Oncoimmunology
|
November 22, 2012
Loss of antigen cross-presentation after complete tumor resection is associated with the generation of protective tumor-specific CD8(+) T-cell immunity
Matthew D Brown, Robbert van der Most, Justin B Vivian, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 17, 2009
Dual control of antitumor CD8 T cells through the programmed death-1/programmed death-ligand 1 pathway and immunosuppressive CD4 T cells: regulation and counterregulation
Andrew J Currie, Amy Prosser, Alison McDonnell, et al.
Pediatric Research
|
October 3, 2019
Cyclic AMP in human preterm infant blood is associated with increased TLR-mediated production of acute-phase and anti-inflammatory cytokines in vitro
Tobias Strunk, Simon D van Haren, Julie Hibbert, et al.
Cancer Immunology, Immunotherapy : CII
|
December 5, 2008
Tumor eradication after cyclophosphamide depends on concurrent depletion of regulatory T cells: a role for cycling TNFR2-expressing effector-suppressor T cells in limiting effective chemotherapy
Robbert G van der Most, Andrew J Currie, Sathish Mahendran, et al.
The Journal of Allergy and Clinical Immunology
|
December 24, 2017
The Western environment reduces innate immune cytokine production in Chinese immigrants
Aarti Saiganesh, Belinda J Hales, Shu Chen, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 22, 2009
Locally administered TLR7 agonists drive systemic antitumor immune responses that are enhanced by anti-CD40 immunotherapy
Steve A Broomfield, Robbert G van der Most, Amy C Prosser, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 40) with videos related to
Sort By:
Page
of 4
Infection and Immunity
|
February 9, 2011
Preterm infants have deficient monocyte and lymphocyte cytokine responses to group B streptococcus
Andrew J Currie, Samantha Curtis, Tobias Strunk, et al.
The Journal of Pediatrics
|
April 8, 2004
Primary immunodeficiency to pneumococcal infection due to a defect in Toll-like receptor signaling
Andrew J Currie, Donald J Davidson, Gregor S D Reid, et al.
Immunity, Inflammation and Disease
|
November 11, 2017
T-cell responses against rhinovirus species A and C in asthmatic and healthy children
Cibele M Gaido, Caitlyn Granland, Ingrid A Laing, et al.
European Journal of Immunology
|
October 16, 2014
Tumor-infiltrating dendritic cells exhibit defective cross-presentation of tumor antigens, but is reversed by chemotherapy
Alison M McDonnell, Willem Joost Lesterhuis, Andrea Khong, et al.
Oncoimmunology
|
November 22, 2012
Loss of antigen cross-presentation after complete tumor resection is associated with the generation of protective tumor-specific CD8(+) T-cell immunity
Matthew D Brown, Robbert van der Most, Justin B Vivian, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 17, 2009
Dual control of antitumor CD8 T cells through the programmed death-1/programmed death-ligand 1 pathway and immunosuppressive CD4 T cells: regulation and counterregulation
Andrew J Currie, Amy Prosser, Alison McDonnell, et al.
Pediatric Research
|
October 3, 2019
Cyclic AMP in human preterm infant blood is associated with increased TLR-mediated production of acute-phase and anti-inflammatory cytokines in vitro
Tobias Strunk, Simon D van Haren, Julie Hibbert, et al.
Cancer Immunology, Immunotherapy : CII
|
December 5, 2008
Tumor eradication after cyclophosphamide depends on concurrent depletion of regulatory T cells: a role for cycling TNFR2-expressing effector-suppressor T cells in limiting effective chemotherapy
Robbert G van der Most, Andrew J Currie, Sathish Mahendran, et al.
The Journal of Allergy and Clinical Immunology
|
December 24, 2017
The Western environment reduces innate immune cytokine production in Chinese immigrants
Aarti Saiganesh, Belinda J Hales, Shu Chen, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 22, 2009
Locally administered TLR7 agonists drive systemic antitumor immune responses that are enhanced by anti-CD40 immunotherapy
Steve A Broomfield, Robbert G van der Most, Amy C Prosser, et al.
Page
of 4